Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000240970 | SCV000300631 | pathogenic | Breast-ovarian cancer, familial, susceptibility to, 2 | 2016-09-08 | reviewed by expert panel | curation | Variant allele predicted to encode a truncated non-functional protein. |
Ambry Genetics | RCV000130156 | SCV000184991 | pathogenic | Hereditary cancer-predisposing syndrome | 2017-03-31 | criteria provided, single submitter | clinical testing | The c.3411dupG pathogenic mutation, located in coding exon 10 of the BRCA2 gene, results from a duplication of one nucleotide at position 3411, causing a translational frameshift with a predicted alternate stop codon (p.Q1138Afs*6). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |